Author: Rootman DS, Krajden M
Publication: J Ocul Pharmacol 1993 Fall;9(3):271-6
Author:
Journal:
Abstract: We have previously shown the pharmacokinetic value of delivering gentamicin to the rabbit anterior segment using the Morgan Therapeutic Lens. The present study utilized an intrastromal injection model of Pseudomonas keratitis to test the therapeutic efficacy of continuous flow delivery of gentamicin with the Morgan Lens. All eyes (n = 52) received an intrastromal injection of approximately 1800 colony-forming units (CFU) of Pseudomonas aeruginosa. At 22 hours after injection, eyes were perfused for 6 hours with saline or gentamicin (1, 2.5 or 5 mg/ml), or received gentamicin drops (13.6 mg/ml) at 15 minutes for four doses, then hourly for 6 hours. Corneas were homogenized and plated to determine bacterial survival, and expressed as log colonies (CFU). Log CFU recovered were 7.37 +/- 0.04, 6.64 +/- 0.20, 5.64 +/- 0.31, and 3.56 +/- 0.50 log CFU for saline perfusion, 1, 2.5, 5 mg/ml gentamicin perfusion respectively. Following six hours of treatment with topical fortified gentamicin drops, 5.93 +/- 0.34 log CFU were recovered. Gentamicin perfusion (5 mg/ml) was significantly different from saline or the other treatment groups (P < 0.05). Continuous corneal perfusion with the Morgan Therapeutic Lens demonstrated an increasing dose response curve with increasing perfusate concentration. It was effective in the treatment of experimental Pseudomonas keratitis.
An ambulance was dispatched to a local industry for a worker who had been sprayed in both eyes with brake fluid under pressure. On scene, our paramedic inserted bilateral Morgan Lenses. He proceeded to flush both eyes simultaneously with approximately 1500 cc N.S.S. on the way to the hospital. The patient tolerated the entire procedure very well, felt much better, and an examination of the patient's eyes, after the Morgan Lens removal, showed no tissue damage. The patient had a full recovery with no complications, thanks to the availability and efficiency of the Morgan Lens system.
Registered Nurse (New Hampshire)
MorTan Inc.
Mailing Address:
P.O. Box 8719
Missoula, MT 59807
U.S.A.
Shipping Address:
329 East Pine St
Missoula, MT 59802
U.S.A.
Toll-Free Telephone: 1-800-423-8659
Telephone: 406-728-2522
Fax: 406-728-9332
Email: mortan@morganlens.com
Hours
Monday - Thursday
7:30 AM - 4:00 PM MT
Friday
8:00 - 1:00 PM MT
The Morgan Lens is used in 90% of hospital emergency departments in the USA and can be inserted in less than 20 seconds. There simply is no other "hands-free" method of eye irrigation. Nothing else frees medical personnel to treat other injuries or to transport the patient while irrigation is underway. Nothing is more effective at treating ocular chemical, thermal, and actinic burns or removing non-embedded foreign bodies, even when the patient's eyes are closed tightly. Its design makes it simple and straightforward to use so minimal training is required.